Antitrust policy in health care markets:
Gespeichert in:
| Beteilige Person: | |
|---|---|
| Format: | Buch |
| Sprache: | Englisch |
| Veröffentlicht: |
Cambridge, United Kingdom ; New York, NY
Cambridge University Press
2023
|
| Schlagwörter: | |
| Abstract: | "In Economics 101, we learn that competition and competitive markets provide the biggest bang for the buck. In a perfectly competitive world, scarce resources are allocated in the most efficient way; the goods and services that are valued most highly are produced in the right quantities and are priced appropriately. Perfectly competitive markets, therefore, maximize social welfare, which is the sum of consumer surplus and producer surplus. Market imperfections can impede the competitive process and introduce inefficiencies which, in time, can reduce the well-being of society. These imperfections include externalities, public goods, asymmetric information, and monopoly power. The public policy response to these market failures is to promote and preserve competition. Concerns over market imperfections are also present in the U.S. health care sector. Departures from competition can lead to poor quality care and cause losses in the hundreds of billions of dollars"-- |
| Umfang: | xxv, 502 Seiten Diagramme |
| ISBN: | 9781316515204 1316515206 9781009096492 1009096494 |
Internformat
MARC
| LEADER | 00000nam a22000008c 4500 | ||
|---|---|---|---|
| 001 | BV048592456 | ||
| 003 | DE-604 | ||
| 005 | 20230508 | ||
| 007 | t| | ||
| 008 | 221202s2023 xx |||| b||| 00||| eng d | ||
| 020 | |a 9781316515204 |c hb |9 978-1-316-51520-4 | ||
| 020 | |a 1316515206 |9 1-316-51520-6 | ||
| 020 | |a 9781009096492 |c pb |9 978-1-009-09649-2 | ||
| 020 | |a 1009096494 |9 1-009-09649-4 | ||
| 035 | |a (DE-599)BVBBV048592456 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M382 | ||
| 100 | 1 | |a Blair, Roger D. |d 1942- |e Verfasser |0 (DE-588)170006166 |4 aut | |
| 245 | 1 | 0 | |a Antitrust policy in health care markets |c Roger D. Blair, Christine Piette Durrance, Tirza J. Angerhofer |
| 264 | 1 | |a Cambridge, United Kingdom ; New York, NY |b Cambridge University Press |c 2023 | |
| 300 | |a xxv, 502 Seiten |b Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 505 | 8 | |a Health Care Markets and Competition Policy -- Antitrust Policy in the United States -- Patents and Monopoly Pricing of Pharmaceuticals -- Patents and Exclusionary Product Hopping -- Bundled Discounts and PeaceHealth -- Collusion in Health Care Markets -- Collusion in Generic Drug Markets -- The Hatch-Waxman Act, Patent Infringement Suits, and Reverse Payments -- The Alleged Insulin Conspiracy -- Licensing of Health Care Professionals -- Monopsony, Dominant Buyers, and Oligopsony -- Countervailing Power -Physician Collective Bargaining -- Group Purchasing Organizations, Monopsony, and Antitrust Policy -- Collusion in the Nurse Labor Market -- Collusion in the Oocyte Market -- No-Poaching Agreements and Antitrust Policy -- The Economics of Horizontal Mergers -- Horizontal Merger Policy -- The Economic Theory of Vertical Integration -- Vertical Merger Policy | |
| 520 | 3 | |a "In Economics 101, we learn that competition and competitive markets provide the biggest bang for the buck. In a perfectly competitive world, scarce resources are allocated in the most efficient way; the goods and services that are valued most highly are produced in the right quantities and are priced appropriately. Perfectly competitive markets, therefore, maximize social welfare, which is the sum of consumer surplus and producer surplus. Market imperfections can impede the competitive process and introduce inefficiencies which, in time, can reduce the well-being of society. These imperfections include externalities, public goods, asymmetric information, and monopoly power. The public policy response to these market failures is to promote and preserve competition. Concerns over market imperfections are also present in the U.S. health care sector. Departures from competition can lead to poor quality care and cause losses in the hundreds of billions of dollars"-- | |
| 653 | 0 | |a Health Care Sector / economics | |
| 653 | 0 | |a Health Policy | |
| 653 | 0 | |a Antitrust Laws / organization & administration | |
| 653 | 0 | |a Marketing of Health Services / methods | |
| 653 | 2 | |a United States | |
| 653 | 0 | |a Medical policy | |
| 653 | 0 | |a Politique sanitaire | |
| 653 | 0 | |a Medical policy | |
| 700 | 1 | |a Durrance, Christine |d 1980- |e Sonstige |0 (DE-588)1019803533 |4 oth | |
| 700 | 1 | |a Angerhofer, Tirza |d 1998- |e Sonstige |0 (DE-588)1279110929 |4 oth | |
| 776 | 0 | 8 | |i Online version |z 978-1-009-09961-5 |a Blair, Roger D. |t Antitrust policy in health care markets |d Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2023 |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-033968140 | |
Datensatz im Suchindex
| _version_ | 1818990127812182016 |
|---|---|
| any_adam_object | |
| author | Blair, Roger D. 1942- |
| author_GND | (DE-588)170006166 (DE-588)1019803533 (DE-588)1279110929 |
| author_facet | Blair, Roger D. 1942- |
| author_role | aut |
| author_sort | Blair, Roger D. 1942- |
| author_variant | r d b rd rdb |
| building | Verbundindex |
| bvnumber | BV048592456 |
| contents | Health Care Markets and Competition Policy -- Antitrust Policy in the United States -- Patents and Monopoly Pricing of Pharmaceuticals -- Patents and Exclusionary Product Hopping -- Bundled Discounts and PeaceHealth -- Collusion in Health Care Markets -- Collusion in Generic Drug Markets -- The Hatch-Waxman Act, Patent Infringement Suits, and Reverse Payments -- The Alleged Insulin Conspiracy -- Licensing of Health Care Professionals -- Monopsony, Dominant Buyers, and Oligopsony -- Countervailing Power -Physician Collective Bargaining -- Group Purchasing Organizations, Monopsony, and Antitrust Policy -- Collusion in the Nurse Labor Market -- Collusion in the Oocyte Market -- No-Poaching Agreements and Antitrust Policy -- The Economics of Horizontal Mergers -- Horizontal Merger Policy -- The Economic Theory of Vertical Integration -- Vertical Merger Policy |
| ctrlnum | (DE-599)BVBBV048592456 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03483nam a22004338c 4500</leader><controlfield tag="001">BV048592456</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20230508 </controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">221202s2023 xx |||| b||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781316515204</subfield><subfield code="c">hb</subfield><subfield code="9">978-1-316-51520-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1316515206</subfield><subfield code="9">1-316-51520-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781009096492</subfield><subfield code="c">pb</subfield><subfield code="9">978-1-009-09649-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1009096494</subfield><subfield code="9">1-009-09649-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048592456</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Blair, Roger D.</subfield><subfield code="d">1942-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)170006166</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antitrust policy in health care markets</subfield><subfield code="c">Roger D. Blair, Christine Piette Durrance, Tirza J. Angerhofer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, United Kingdom ; New York, NY</subfield><subfield code="b">Cambridge University Press</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxv, 502 Seiten</subfield><subfield code="b">Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Health Care Markets and Competition Policy -- Antitrust Policy in the United States -- Patents and Monopoly Pricing of Pharmaceuticals -- Patents and Exclusionary Product Hopping -- Bundled Discounts and PeaceHealth -- Collusion in Health Care Markets -- Collusion in Generic Drug Markets -- The Hatch-Waxman Act, Patent Infringement Suits, and Reverse Payments -- The Alleged Insulin Conspiracy -- Licensing of Health Care Professionals -- Monopsony, Dominant Buyers, and Oligopsony -- Countervailing Power -Physician Collective Bargaining -- Group Purchasing Organizations, Monopsony, and Antitrust Policy -- Collusion in the Nurse Labor Market -- Collusion in the Oocyte Market -- No-Poaching Agreements and Antitrust Policy -- The Economics of Horizontal Mergers -- Horizontal Merger Policy -- The Economic Theory of Vertical Integration -- Vertical Merger Policy</subfield></datafield><datafield tag="520" ind1="3" ind2=" "><subfield code="a">"In Economics 101, we learn that competition and competitive markets provide the biggest bang for the buck. In a perfectly competitive world, scarce resources are allocated in the most efficient way; the goods and services that are valued most highly are produced in the right quantities and are priced appropriately. Perfectly competitive markets, therefore, maximize social welfare, which is the sum of consumer surplus and producer surplus. Market imperfections can impede the competitive process and introduce inefficiencies which, in time, can reduce the well-being of society. These imperfections include externalities, public goods, asymmetric information, and monopoly power. The public policy response to these market failures is to promote and preserve competition. Concerns over market imperfections are also present in the U.S. health care sector. Departures from competition can lead to poor quality care and cause losses in the hundreds of billions of dollars"--</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Health Care Sector / economics</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Health Policy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Antitrust Laws / organization & administration</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Marketing of Health Services / methods</subfield></datafield><datafield tag="653" ind1=" " ind2="2"><subfield code="a">United States</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medical policy</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Politique sanitaire</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Medical policy</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Durrance, Christine</subfield><subfield code="d">1980-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1019803533</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Angerhofer, Tirza</subfield><subfield code="d">1998-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1279110929</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Online version</subfield><subfield code="z">978-1-009-09961-5</subfield><subfield code="a">Blair, Roger D.</subfield><subfield code="t">Antitrust policy in health care markets</subfield><subfield code="d">Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2023</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033968140</subfield></datafield></record></collection> |
| id | DE-604.BV048592456 |
| illustrated | Not Illustrated |
| indexdate | 2024-12-20T19:49:26Z |
| institution | BVB |
| isbn | 9781316515204 1316515206 9781009096492 1009096494 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033968140 |
| open_access_boolean | |
| owner | DE-M382 |
| owner_facet | DE-M382 |
| physical | xxv, 502 Seiten Diagramme |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Cambridge University Press |
| record_format | marc |
| spelling | Blair, Roger D. 1942- Verfasser (DE-588)170006166 aut Antitrust policy in health care markets Roger D. Blair, Christine Piette Durrance, Tirza J. Angerhofer Cambridge, United Kingdom ; New York, NY Cambridge University Press 2023 xxv, 502 Seiten Diagramme txt rdacontent n rdamedia nc rdacarrier Health Care Markets and Competition Policy -- Antitrust Policy in the United States -- Patents and Monopoly Pricing of Pharmaceuticals -- Patents and Exclusionary Product Hopping -- Bundled Discounts and PeaceHealth -- Collusion in Health Care Markets -- Collusion in Generic Drug Markets -- The Hatch-Waxman Act, Patent Infringement Suits, and Reverse Payments -- The Alleged Insulin Conspiracy -- Licensing of Health Care Professionals -- Monopsony, Dominant Buyers, and Oligopsony -- Countervailing Power -Physician Collective Bargaining -- Group Purchasing Organizations, Monopsony, and Antitrust Policy -- Collusion in the Nurse Labor Market -- Collusion in the Oocyte Market -- No-Poaching Agreements and Antitrust Policy -- The Economics of Horizontal Mergers -- Horizontal Merger Policy -- The Economic Theory of Vertical Integration -- Vertical Merger Policy "In Economics 101, we learn that competition and competitive markets provide the biggest bang for the buck. In a perfectly competitive world, scarce resources are allocated in the most efficient way; the goods and services that are valued most highly are produced in the right quantities and are priced appropriately. Perfectly competitive markets, therefore, maximize social welfare, which is the sum of consumer surplus and producer surplus. Market imperfections can impede the competitive process and introduce inefficiencies which, in time, can reduce the well-being of society. These imperfections include externalities, public goods, asymmetric information, and monopoly power. The public policy response to these market failures is to promote and preserve competition. Concerns over market imperfections are also present in the U.S. health care sector. Departures from competition can lead to poor quality care and cause losses in the hundreds of billions of dollars"-- Health Care Sector / economics Health Policy Antitrust Laws / organization & administration Marketing of Health Services / methods United States Medical policy Politique sanitaire Durrance, Christine 1980- Sonstige (DE-588)1019803533 oth Angerhofer, Tirza 1998- Sonstige (DE-588)1279110929 oth Online version 978-1-009-09961-5 Blair, Roger D. Antitrust policy in health care markets Cambridge, United Kingdom ; New York, NY : Cambridge University Press, 2023 |
| spellingShingle | Blair, Roger D. 1942- Antitrust policy in health care markets Health Care Markets and Competition Policy -- Antitrust Policy in the United States -- Patents and Monopoly Pricing of Pharmaceuticals -- Patents and Exclusionary Product Hopping -- Bundled Discounts and PeaceHealth -- Collusion in Health Care Markets -- Collusion in Generic Drug Markets -- The Hatch-Waxman Act, Patent Infringement Suits, and Reverse Payments -- The Alleged Insulin Conspiracy -- Licensing of Health Care Professionals -- Monopsony, Dominant Buyers, and Oligopsony -- Countervailing Power -Physician Collective Bargaining -- Group Purchasing Organizations, Monopsony, and Antitrust Policy -- Collusion in the Nurse Labor Market -- Collusion in the Oocyte Market -- No-Poaching Agreements and Antitrust Policy -- The Economics of Horizontal Mergers -- Horizontal Merger Policy -- The Economic Theory of Vertical Integration -- Vertical Merger Policy |
| title | Antitrust policy in health care markets |
| title_auth | Antitrust policy in health care markets |
| title_exact_search | Antitrust policy in health care markets |
| title_full | Antitrust policy in health care markets Roger D. Blair, Christine Piette Durrance, Tirza J. Angerhofer |
| title_fullStr | Antitrust policy in health care markets Roger D. Blair, Christine Piette Durrance, Tirza J. Angerhofer |
| title_full_unstemmed | Antitrust policy in health care markets Roger D. Blair, Christine Piette Durrance, Tirza J. Angerhofer |
| title_short | Antitrust policy in health care markets |
| title_sort | antitrust policy in health care markets |
| work_keys_str_mv | AT blairrogerd antitrustpolicyinhealthcaremarkets AT durrancechristine antitrustpolicyinhealthcaremarkets AT angerhofertirza antitrustpolicyinhealthcaremarkets |